Ep. 140 - Turbulence at BIO, Plus 4Q Preview & the Distillery

from BioCentury This Week · host BioCentury

On the latest BioCentury This Week podcast, Washington Editor Steve Usdin details the circumstances leading up to Michelle McMurry-Heath’s resignation as CEO of BIO on Monday. The podcast team also discuss BioCentury’s 4Q22 Financial Markets Preview, with Associate Editor Stephen Hansen assessing biotech’s attempt to emerge from the ongoing bear market recovery as inflation and rising interest rates foster a risk-off environment. Senior Editor Karen Tkach Tuzman discusses the latest translational tidbits from BioCentury’s Distillery and the impact Nobel Prize laureate Carolyn Bertozzi has had on the biotech industry.Reach us by sending a text

Episode metadata supplied by the publisher feed · Published Oct 11, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep. 140 - Turbulence at BIO, Plus 4Q Preview & the Distillery

0:00 29:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioCentury This Week?

This episode is 29 minutes long.

When was this BioCentury This Week episode published?

This episode was published on October 11, 2022.

Can I download this BioCentury This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!